BCAR1 and breast carcinoma: In breast cancer models the expression of the Cas family scaffold members NEDD9 (HEF1, Cas-L) or p130Cas (BCAR1) promotes phenotypes associated with epithelial-to-mesenchymal transition (EMT) [27] in a Src kinase-dependent manner [27-29].